These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20083199)

  • 1. Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.
    Bader Lange ML; St Clair D; Markesbery WR; Studzinski CM; Murphy MP; Butterfield DA
    Neurobiol Dis; 2010 Apr; 38(1):104-15. PubMed ID: 20083199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.
    Sultana R; Robinson RA; Di Domenico F; Abdul HM; St Clair DK; Markesbery WR; Cai J; Pierce WM; Butterfield DA
    J Proteomics; 2011 Oct; 74(11):2430-40. PubMed ID: 21726674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
    Flood DG; Reaume AG; Dorfman KS; Lin YG; Lang DM; Trusko SP; Savage MJ; Annaert WG; De Strooper B; Siman R; Scott RW
    Neurobiol Aging; 2002; 23(3):335-48. PubMed ID: 11959395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease.
    Mohmmad Abdul H; Butterfield DA
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):140-8. PubMed ID: 15955457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
    Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
    Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
    Siman R; Reaume AG; Savage MJ; Trusko S; Lin YG; Scott RW; Flood DG
    J Neurosci; 2000 Dec; 20(23):8717-26. PubMed ID: 11102478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
    Huang Q; Aluise CD; Joshi G; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
    J Neurosci Res; 2010 Sep; 88(12):2618-29. PubMed ID: 20648652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
    Sompol P; Ittarat W; Tangpong J; Chen Y; Doubinskaia I; Batinic-Haberle I; Abdul HM; Butterfield DA; St Clair DK
    Neuroscience; 2008 Apr; 153(1):120-30. PubMed ID: 18353561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.
    Anantharaman M; Tangpong J; Keller JN; Murphy MP; Markesbery WR; Kiningham KK; St Clair DK
    Am J Pathol; 2006 May; 168(5):1608-18. PubMed ID: 16651627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.
    Abdul HM; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2008 Nov; 45(10):1420-5. PubMed ID: 18762245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
    Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
    Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.
    Robinson RA; Joshi G; Huang Q; Sultana R; Baker AS; Cai J; Pierce W; St Clair DK; Markesbery WR; Butterfield DA
    Proteomics; 2011 Nov; 11(21):4243-56. PubMed ID: 21954051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
    Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
    J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression.
    Saito T; Matsuba Y; Yamazaki N; Hashimoto S; Saido TC
    J Neurosci; 2016 Sep; 36(38):9933-6. PubMed ID: 27656030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease.
    Emre C; Do KV; Jun B; Hjorth E; Alcalde SG; Kautzmann MI; Gordon WC; Nilsson P; Bazan NG; Schultzberg M
    Acta Neuropathol Commun; 2021 Jun; 9(1):116. PubMed ID: 34187579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice.
    Studzinski CM; Li F; Bruce-Keller AJ; Fernandez-Kim SO; Zhang L; Weidner AM; Markesbery WR; Murphy MP; Keller JN
    J Neurochem; 2009 Feb; 108(4):860-6. PubMed ID: 19046405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
    Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
    Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.